Fine Organics
United Kingdom Updated 9 July 2026
Fine Organics is an API manufacturer based in United Kingdom. It holds one active US drug master file and one valid CEP. Its GMP standing is certified by MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 17 June 2022 as VAI. Customs aggregates show $618K of exports covering 9 molecules to 4 destinations in 2025.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 17 June 2022 VAI US FDA
- 15 February 2017 NAI US FDA
- 7 July 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Middlesbrough, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3002807000 |
What they file, and where
| Molecule | Regulators | Docs |
| Ketamine | EDQM, US FDA | 2 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MHRA (UK) | None | 2 |
Scale
| Year | Revenue | Exports | Destinations |
| 2026 YTD | Not reported | $29K | 2 |
| 2025 | Not reported | $618K | 4 |
| 2024 | Not reported | $1.7M | 6 |
| 2023 | Not reported | $3.7M | 10 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Comparing suppliers?
Choose your molecules and target markets. Fine Organics comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 17 June 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates
- Customs aggregates
- Export values, molecule and destination counts